Pancreatic ductal adenocarcinoma (PDAC) is among the most lethal malignancies whose main characterization is the high frequency of Kirsten Rat Sarcoma-activating mutations (KRAS) [1,2,3]. Here, KRAS is linked to pancreatic ductal adenocarcinoma.